← Open Payments lookup

KATHRYN VALAZAK: Open Payments

NPI 1285267690 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$983 in 57 payments from 13 companies in 2025. Trend: 2023 $1,708 · 2024 $1,557 · 2025 $983

Food & beverage: $983
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$192
ABBVIE INC.12$158
Teva Pharmaceuticals USA, Inc.10$141
Neurocrine BioSciences, Inc.5$89
Vanda Pharmaceuticals Inc.3$87
Lundbeck LLC3$66
Alkermes, Inc.3$60
Collegium Pharmaceutical, Inc.2$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44
Janssen Pharmaceuticals, Inc2$36

Products named: REXULTI, VRAYLAR, INGREZZA, FANAPT, UZEDY, ABILIFY MAINTENA, ARISTADA, AUSTEDO XR.

Industry payments across PA — which companies pay providers there.